Answers are grounded in this paper and cite their sources.
Research demonstrates enhanced atherosclerosis imaging with targeted silica nanoparticles, implying potential therapeutic use.
Atherosclerosis remains the primary cause underlying cardiovascular diseases, however, there is no plaque-targeting pharmacotherapy clinically available. Nebivolol (NB), a third-generation beta-blocker clinically used to treat hypertension and heart failure, exerts...
No takes yet. Share an insight, caveat, or question.
Lin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: